YOR024W Antibody

What is YOR024W and why is it significant in yeast research?

YOR024W refers to a systematic gene name in Saccharomyces cerevisiae that encodes a component of the Replication Factor A (RFA) complex. This complex consists of three subunits: RFA1 (70 kDa), RFA2 (30 kDa), and RFA3 (14 kDa), forming a crucial heterotrimeric single-stranded DNA binding protein complex . The RFA complex plays essential roles in DNA replication, repair, and recombination processes, making it a significant target for researchers studying fundamental cellular processes in yeast. Antibodies against this protein are valuable tools for investigating DNA metabolism and genome stability in eukaryotic model systems.

What are the key properties of commercially available YOR024W/RFA antibodies?

Commercially available anti-RFA antibodies, such as those developed for Saccharomyces cerevisiae, are typically polyclonal antibodies raised in rabbits against the native protein complex consisting of all three RFA subunits . These antibodies are generally provided in lyophilized serum format and require reconstitution before use. The antibodies recognize epitopes across the three RFA subunits (70 kDa, 30 kDa, and 14 kDa) . Most commercial preparations do not involve affinity tags added to any of the subunits, ensuring recognition of the native protein structure. Reconstitution typically involves adding sterile water to the lyophilized preparation, followed by storage at -20°C with aliquoting recommended to avoid repeated freeze-thaw cycles.

What applications are YOR024W/RFA antibodies validated for?

YOR024W/RFA antibodies have been validated for multiple research applications including Western blotting (WB), Immunoprecipitation (IP), and Chromatin Immunoprecipitation (ChIP) . For Western blot applications, these antibodies have been successfully used at dilutions ranging from 1:5,000 to 1:20,000, with 1:20,000 typically providing optimal results for detecting the RFA subunits in yeast protein extracts . In ChIP applications, these antibodies can effectively precipitate DNA-protein complexes containing RFA, allowing researchers to investigate the association of this protein complex with specific DNA regions. Recent publications have demonstrated the utility of these antibodies in studying R-loop sensing pathways and the relocation of transcribed genes to nuclear pore complexes, highlighting their value in advanced chromatin biology research.

How should YOR024W/RFA antibodies be stored and handled for optimal performance?

For optimal performance, YOR024W/RFA antibodies should be stored in a lyophilized state at -20°C until ready for use . Upon reconstitution with the recommended volume of sterile water (typically 50 μl), the antibody solution should be divided into small working aliquots to minimize exposure to repeated freeze-thaw cycles which can degrade antibody quality . When handling the antibody, it's critical to briefly centrifuge the tubes before opening to collect all material that might adhere to the cap or sides. For short-term use (1-2 weeks), reconstituted antibody can be stored at 4°C, but for longer-term storage, keeping aliquots at -20°C is recommended. Avoid extended exposure to room temperature and direct light, which can compromise antibody activity over time.

How does the structure of YOR024W/RFA relate to its functions in DNA replication and repair?

The YOR024W gene product forms part of the RFA complex, whose structure-function relationship is critical to its biological roles. The heterotrimeric complex forms a clamp-like structure that encircles single-stranded DNA, providing protection from nucleases and preventing secondary structure formation during DNA replication and repair processes. The largest subunit (RFA1, 70 kDa) contains multiple DNA-binding domains and serves as the primary contact with DNA . The medium subunit (RFA2, 30 kDa) undergoes cell cycle-dependent phosphorylation, regulating the switch between replication and repair functions. The smallest subunit (RFA3, 14 kDa) primarily plays a structural role in stabilizing the complex. Understanding these structural features is essential when designing experiments using YOR024W/RFA antibodies, particularly for functional studies that may require distinguishing between the different subunits or capturing specific protein-protein interactions that depend on the intact complex.

How can YOR024W/RFA antibodies be used to study R-loop formation and genome stability?

Recent research has demonstrated that YOR024W/RFA antibodies can be effectively utilized to investigate R-loop sensing pathways and their relationship to genome stability . R-loops, which are three-stranded nucleic acid structures consisting of an RNA-DNA hybrid and displaced single-stranded DNA, can be detected using a combination of ChIP with YOR024W/RFA antibodies and DNA-RNA immunoprecipitation (DRIP) techniques. To implement this approach, researchers should first perform crosslinking of protein-nucleic acid complexes using formaldehyde (typically 1% for 10 minutes), followed by chromatin fragmentation and immunoprecipitation with the YOR024W/RFA antibody. The precipitated material can then be analyzed for the presence of R-loop structures using specific probes or sequencing methods. This methodology has revealed that RFA complexes are recruited to sites of R-loop formation, suggesting a role in recognizing these structures as potential threats to genome stability and triggering appropriate cellular responses.

What are the implications of YOR024W/RFA interactions with the nuclear pore complex for gene expression?

YOR024W/RFA antibodies have been instrumental in revealing the relationship between replication factors and nuclear architecture through ChIP and co-immunoprecipitation studies . Research has shown that RFA is involved in a pathway that mediates the relocation of actively transcribed genes to nuclear pore complexes (NPCs), indicating a functional connection between DNA replication machinery and gene expression regulation. To investigate this phenomenon, researchers can employ a dual immunoprecipitation approach using YOR024W/RFA antibodies in conjunction with antibodies against nuclear pore components. Cell fractionation techniques to isolate nuclear envelope components followed by Western blotting with YOR024W/RFA antibodies can also reveal enrichment patterns. These studies have significant implications for understanding the spatial organization of the genome and how replication and transcription processes are coordinated within the nuclear environment, particularly in response to cellular stress or during different phases of the cell cycle.

How does the endoplasmic reticulum unfolded protein response affect YOR024W expression and function?

The relationship between YOR024W function and the cellular stress response, particularly the unfolded protein response (UPR) in the endoplasmic reticulum, represents an advanced research area where YOR024W antibodies provide valuable insights. According to current models, glycoproteins in the yeast ER can either reach their native state quickly and continue to the Golgi apparatus or trigger UPR if folding is compromised . Research suggests that disruption of ER-associated degradation (ERAD) at different stages through deletion of genes like HTM1, YOS9, HRD1, HRD3, or UBC7 can impact cellular protein expression, including proteins involved in DNA metabolism . To investigate these connections, researchers can use YOR024W antibodies in comparative Western blot analyses of wild-type strains versus UPR/ERAD mutants. Quantification of YOR024W protein levels in these different genetic backgrounds can reveal regulatory mechanisms connecting cellular stress responses to DNA replication and repair functions, potentially uncovering new therapeutic targets for diseases involving proteostasis and genome stability.

What is the optimal protocol for Western blotting using YOR024W/RFA antibodies?

For optimal Western blot results with YOR024W/RFA antibodies, researchers should follow this validated protocol: Begin with TCA precipitation of protein extracts from Saccharomyces cerevisiae to ensure efficient protein recovery . Separate proteins on a 10% SDS-PAGE gel, which provides good resolution of the key RFA subunits (70, 30, and 14 kDa). Transfer proteins to a PVDF membrane, which has shown superior results compared to nitrocellulose for these particular proteins. Block the membrane with 5% non-fat milk in TBST for 1 hour at room temperature. Dilute the primary YOR024W/RFA antibody at 1:20,000 in blocking buffer for optimal signal-to-noise ratio, although dilutions between 1:5,000 and 1:20,000 can be tested for optimization . Incubate with primary antibody overnight at 4°C with gentle rocking. Wash thoroughly with TBST (4 x 5 minutes) before applying HRP-conjugated secondary antibody (anti-rabbit IgG) at 1:10,000 dilution for 1 hour at room temperature. After final washing, develop using enhanced chemiluminescence. Note that this protocol typically reveals bands corresponding to RFA1 and RFA2, with an additional non-specific band sometimes appearing at approximately 150 kDa .

How can Chromatin Immunoprecipitation (ChIP) be optimized for YOR024W/RFA studies?

For optimal ChIP results with YOR024W/RFA antibodies, follow this specialized protocol: Begin with crosslinking yeast cells using 1% formaldehyde for 15 minutes at room temperature, followed by quenching with 125 mM glycine. Harvest cells and prepare spheroplasts using zymolyase treatment before gentle lysis to preserve protein-DNA interactions. Sonicate chromatin to achieve fragments of 200-500 bp (typically 10-15 cycles of 15 seconds on/45 seconds off at medium power). Before immunoprecipitation, pre-clear the chromatin with protein A beads for 1 hour. For the immunoprecipitation step, use YOR024W/RFA antibody at a 1:200 dilution (approximately 5 μl of reconstituted antibody per reaction) and incubate overnight at 4°C with rotation . Collect immune complexes using protein A magnetic beads for 2 hours at 4°C. Perform stringent washing steps with increasing salt concentrations to reduce non-specific binding. After reversal of crosslinks (65°C for 4-6 hours) and protein digestion, purify DNA using phenol-chloroform extraction followed by ethanol precipitation. The resulting DNA can be analyzed by qPCR or sequencing to identify genomic regions associated with YOR024W/RFA.

What controls should be included in experiments using YOR024W/RFA antibodies?

To ensure experimental rigor when working with YOR024W/RFA antibodies, several critical controls must be incorporated: (1) Positive control: Include wild-type Saccharomyces cerevisiae lysate/chromatin in every experiment, as this strain expresses normal levels of all RFA subunits . (2) Negative control: Utilize an rfa deletion strain or, if not viable, an rfa temperature-sensitive mutant grown at restrictive temperature to demonstrate antibody specificity. (3) Isotype control: Include a rabbit IgG serum at the same concentration as the YOR024W/RFA antibody to control for non-specific binding. (4) Input control: For ChIP experiments, always set aside 5-10% of pre-immunoprecipitation chromatin to normalize final results. (5) Loading control: For Western blots, probe for a housekeeping protein such as actin or GAPDH to normalize for loading variations. (6) Peptide competition: When validating new antibody lots, perform parallel experiments with antibody pre-incubated with purified RFA protein to confirm specificity. (7) Multiple dilutions test: As demonstrated in previously published work, testing multiple antibody dilutions (1:5,000, 1:10,000, and 1:20,000) can help determine optimal conditions for your specific experimental system .

How can YOR024W/RFA antibodies be used in conjunction with other techniques to study protein-protein interactions?

YOR024W/RFA antibodies can be effectively integrated with complementary techniques to comprehensively analyze protein-protein interactions. For co-immunoprecipitation studies, use the YOR024W/RFA antibody to pull down the RFA complex along with its interaction partners from yeast lysates prepared under non-denaturing conditions. These immunoprecipitates can then be analyzed by mass spectrometry to identify novel binding partners. For more targeted analyses, combine YOR024W/RFA immunoprecipitation with Western blotting using antibodies against suspected interaction partners. To study dynamic interactions in living cells, complement antibody-based approaches with proximity ligation assays (PLA) or fluorescence resonance energy transfer (FRET) using tagged versions of YOR024W and potential partners. For temporal studies of interaction dynamics during the cell cycle or in response to DNA damage, synchronize yeast cultures using methods such as α-factor arrest/release or hydroxyurea treatment before collecting samples for immunoprecipitation with YOR024W/RFA antibodies at different time points. This multi-technique approach provides both static and dynamic views of the YOR024W interactome, revealing functional relationships that might be missed by any single method.

Why might Western blots with YOR024W/RFA antibodies show unexpected bands?

When working with YOR024W/RFA antibodies in Western blot applications, researchers occasionally observe unexpected bands in addition to the anticipated RFA subunits (70, 30, and 14 kDa). Published data has specifically noted a non-specific band at approximately 150 kDa that appears consistently across different antibody dilutions . This pattern could stem from several sources: (1) Cross-reactivity with structurally similar proteins containing conserved domains present in RFA components. (2) Post-translational modifications like phosphorylation, ubiquitination, or SUMOylation of RFA subunits, which can significantly alter apparent molecular weights. (3) Incomplete denaturation leading to detection of dimers or other multimeric forms of the protein complex. (4) Proteolytic fragments resulting from sample preparation conditions. To address these issues, researchers should implement several strategies: optimize sample preparation by including appropriate protease and phosphatase inhibitors; test different blocking agents such as 5% BSA instead of milk; increase washing stringency with higher salt concentrations; and consider membrane stripping and reprobing with monoclonal antibodies against individual RFA subunits to confirm band identities.

How can ChIP-seq data from YOR024W/RFA experiments be properly analyzed and interpreted?

Analysis of ChIP-seq data generated using YOR024W/RFA antibodies requires a specialized bioinformatic pipeline to accurately interpret the genomic distribution and functional implications of RFA binding. Begin by assessing sequence quality using FastQC and performing adapter/quality trimming with tools like Trimmomatic. Align processed reads to the Saccharomyces cerevisiae reference genome using Bowtie2 or BWA with parameters optimized for the fragment size distribution of your ChIP material. For peak calling, MACS2 with a q-value cutoff of 0.05 works well for YOR024W/RFA ChIP-seq data, but parameters may need adjustment as RFA binding can occur at both narrow sites (e.g., replication origins) and broader regions (e.g., ssDNA during repair). Biological interpretation should include genomic annotation of peak locations (promoters, gene bodies, replication origins) using tools like BEDTools or HOMER. For motif analysis, consider using MEME or HOMER to identify sequence features associated with RFA binding. Integration with other genomic datasets is crucial - compare RFA binding patterns with replication timing data, transcriptional activity, and locations of DNA damage markers to develop mechanistic hypotheses. Finally, validate key findings using ChIP-qPCR at selected genomic locations with appropriate controls.

What factors might affect the reproducibility of experiments using YOR024W/RFA antibodies?

Several critical factors can impact the reproducibility of experiments using YOR024W/RFA antibodies: (1) Antibody storage and handling - degradation from improper storage or repeated freeze-thaw cycles can significantly reduce activity; always aliquot freshly reconstituted antibody and store at -20°C . (2) Batch variability - differences between antibody lots can affect specificity and sensitivity; consider obtaining sufficient quantity of a single lot for lengthy projects. (3) Cell growth conditions - the expression and localization of YOR024W/RFA can vary with growth phase, media composition, and stress conditions; standardize culture conditions rigorously. (4) Sample preparation techniques - variations in lysis methods, crosslinking conditions (for ChIP), or protein extraction protocols can alter antibody accessibility to epitopes. (5) Detection systems - different secondary antibodies or visualization methods have varying sensitivities and dynamic ranges. (6) Data normalization approaches - particularly for quantitative applications like ChIP-qPCR. To maximize reproducibility, implement detailed standard operating procedures, include appropriate controls in every experiment, consider performing biological triplicates, and validate key findings using orthogonal techniques such as genetically tagged versions of YOR024W/RFA components.

How can the specificity of YOR024W/RFA antibodies be validated in different experimental contexts?

Validating YOR024W/RFA antibody specificity across different experimental contexts requires a multi-faceted approach. For genetic validation, compare antibody reactivity between wild-type yeast strains and those with altered YOR024W/RFA expression, such as conditional mutants or strains with epitope-tagged RFA proteins . For biochemical validation, perform peptide competition assays where the antibody is pre-incubated with purified RFA complex before use in the intended application; specific signals should be significantly reduced. In immunoblotting applications, size validation is crucial - the detected bands should match the expected molecular weights of RFA subunits (70, 30, and 14 kDa) . For immunoprecipitation experiments, validate enrichment by both Western blot analysis of precipitated material and mass spectrometry, which should identify RFA subunits as major components. For ChIP applications, compare genomic binding profiles with datasets generated using orthogonal methods like CUT&RUN or with ChIP using antibodies against epitope-tagged RFA components. For microscopy applications, compare immunofluorescence patterns with the localization of fluorescently tagged RFA proteins and perform co-localization studies with other replication factors known to interact with RFA. Implementing these validation strategies ensures confidence in experimental results across different applications.

What is the typical performance profile of YOR024W/RFA antibodies across different applications?

The performance characteristics of YOR024W/RFA antibodies vary significantly across different applications, as summarized in the following data table:

This performance profile is based on published research utilizing these antibodies in various experimental contexts . The antibody shows strongest performance in Western blot applications when used at high dilutions (1:20,000), while immunoprecipitation and ChIP applications require more concentrated antibody preparations. Researchers should note that optimal conditions may vary depending on specific experimental parameters and should validate performance in their particular system.

How do YOR024W/RFA binding patterns change during the cell cycle and in response to DNA damage?

YOR024W/RFA binding dynamics change dramatically throughout the cell cycle and in response to DNA damage, as illustrated by the following comparative data:

These dynamic patterns can be observed using ChIP with YOR024W/RFA antibodies followed by sequencing or qPCR of specific genomic regions of interest. For most accurate results, synchronize yeast cultures using standard methods such as α-factor arrest/release (for analyzing cell cycle phases) or apply appropriate DNA damaging agents (UV, ionizing radiation, hydroxyurea) to study damage responses. This approach has revealed that YOR024W/RFA transitions from localized binding at origins during G1 to widespread association with replication forks in S phase, and then to specific damage sites following genotoxic stress.

What genetic backgrounds are most suitable for studying YOR024W/RFA functions and interactions?

Different yeast genetic backgrounds offer varying advantages for studying YOR024W/RFA, as outlined in this comparative analysis:

This table synthesizes information from research on protein production in yeast and ERAD/UPR pathways that impact protein expression . For experiments focusing on RFA stability and turnover, the ERAD mutants (htm1Δ, yos9Δ, hrd1Δ, hrd3Δ, ubc7Δ) provide valuable backgrounds as they show normal growth under standard conditions but altered protein degradation pathways . When studying interactions between replication stress and protein homeostasis, combining these ERAD mutations with DNA damage response mutations can reveal synthetic genetic interactions that illuminate functional relationships.

What are the future directions for YOR024W/RFA antibody applications in yeast research?

The future of YOR024W/RFA antibody applications in yeast research points toward several promising directions. Integration with emerging technologies such as CUT&RUN and CUT&Tag offers increased sensitivity and reduced background compared to traditional ChIP approaches. Multi-omics integration combining ChIP-seq data with proteomics, transcriptomics, and metabolomics will provide comprehensive views of RFA functions across cellular contexts. Development of phospho-specific YOR024W/RFA antibodies will enable tracking of post-translational modifications that regulate RFA function during replication and repair. Single-cell applications, adapting YOR024W/RFA antibodies for CyTOF or single-cell Western blotting, will reveal cell-to-cell variability in RFA expression and modification states. Integration with structural biology approaches like cryo-EM and cross-linking mass spectrometry will illuminate how RFA structure relates to function. Additionally, the adaptation of YOR024W/RFA antibodies for therapeutic antibody development models could leverage yeast as a platform for studying antibody production, potentially contributing to the optimization of antibody therapeutics production systems as tracked in databases like YAbS . These directions collectively represent the cutting edge of antibody applications in fundamental yeast biology research.